Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China flag China · Delayed Price · Currency is CNY
7.63
-0.07 (-0.91%)
Nov 17, 2026, 3:04 PM CST

SHE:300009 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
2,3332,6432,5332,8612,3272,160
Other Revenue
3.193.192.654.574.188.5
2,3362,6472,5362,8662,3312,169
Revenue Growth
-9.36%4.36%-11.51%22.94%7.48%27.47%
Cost of Revenue
594.68660.63581.16626.15513.47436.15
Gross Profit
1,7411,9861,9552,2401,8181,733
Selling, General & Admin
822.79947.93986.631,035871.18942.68
Research & Development
185.96219.45201.29254.68166.01166.54
Other Operating Expenses
24.479.80.6817.2119.3219.47
Operating Expenses
1,0431,1861,1961,3271,0621,133
Operating Income
698.92800.39759.09912.92755.7599.3
Interest Expense
-1.78-1.93-2.4-1.87-1.52-1.62
Interest & Investment Income
13.5721.6820.425.899.6111.52
Currency Exchange Gain (Loss)
-2.97-2.970.080.860.063.92
Other Non Operating Income (Expenses)
-0.79-3.36-2.79-1.1126.47-12.29
EBT Excluding Unusual Items
706.96813.81774.4916.69790.32600.83
Impairment of Goodwill
------322.6
Gain (Loss) on Sale of Investments
7.161.8810.52-15.4419.86-2.24
Gain (Loss) on Sale of Assets
6.676.31.090.12-1.21.68
Asset Writedown
2.17-0.38-0.15-1.49-4.47-0.84
Other Unusual Items
12.411.5517.1620.0529.3418.28
Pretax Income
735.37833.16803.02919.93833.85295.12
Income Tax Expense
72.0185.8287.1861.3496.1991.73
Earnings From Continuing Operations
663.36747.34715.84858.59737.66203.39
Minority Interest in Earnings
-11.69-12.15-8.89-11.36-34.43.24
Net Income
651.66735.19706.95847.23703.26206.63
Net Income to Common
651.66735.19706.95847.23703.26206.63
Net Income Growth
-2.55%4.00%-16.56%20.47%240.35%-42.44%
Shares Outstanding (Basic)
1,6711,6711,6831,6741,6351,589
Shares Outstanding (Diluted)
1,6711,6711,6831,6741,6351,589
Shares Change
-0.11%-0.73%0.57%2.34%2.90%-2.58%
EPS (Basic)
0.390.440.420.510.430.13
EPS (Diluted)
0.390.440.420.510.430.13
EPS Growth
-2.44%4.76%-17.03%17.72%230.77%-40.91%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
512.92736.33568.15757.64224.64460.94
Free Cash Flow Per Share
0.310.440.340.450.140.29
Dividend Per Share
0.2500.2500.2500.2500.2500.200
Dividend Growth
66.67%0%0%0%25.00%19.98%
Gross Margin
74.54%75.04%77.08%78.15%77.97%79.89%
Operating Margin
29.92%30.24%29.93%31.86%32.42%27.63%
Profit Margin
27.89%27.78%27.88%29.56%30.17%9.53%
Free Cash Flow Margin
21.96%27.82%22.40%26.44%9.64%21.25%
EBITDA
816.19915.31870.9993.44836.21676.71
EBITDA Margin
34.94%34.59%34.34%34.67%35.87%31.20%
D&A For EBITDA
117.27114.93111.880.5280.577.41
EBIT
698.92800.39759.09912.92755.7599.3
EBIT Margin
29.92%30.24%29.93%31.86%32.42%27.63%
Effective Tax Rate
9.79%10.30%10.86%6.67%11.54%31.08%
Revenue as Reported
2,3362,6472,5362,8662,3312,169
Advertising Expenses
-57.5233.4411.128.249.96